Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells
Z.-C. Dong, D. Zhang, S.-B. Wang, Z.-Q. Lin Department of Urology, Gansu Nephro-Urological Clinical Center, Key Laboratory of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells, by Z.-C. Dong, D. Zhang, S.-B. Wang, Z.-Q. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22 (10): 3018-3026–DOI: 10.26355/eurrev_201805_15059–PMID: 29863246” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadTarget inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Z.-C. Dong, D. Zhang, S.-B. Wang, Z.-Q. Lin
Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 20
Pages: 10301-10301
DOI: 10.26355/eurrev_202010_23351